Nos2 | nitric oxide synthase 2, inducible
Physiological systems
18 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Vision/eye Behavior/neurological
16 No significant impact
6 Not tested
Data collections
Gene metrics:3Significant phenotypes
1Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
hyperactivity | 1 supporting dataset | Nos2em1(IMPC)Bay | homozygote | Early adult | 9.32x10-5 | ||
abnormal eye anterior chamber depth | 1 supporting dataset | Nos2em1(IMPC)Bay | homozygote | Early adult | 1.43x10-6 | ||
decreased thigmotaxis | 2 supporting datasets | Nos2em1(IMPC)Bay | homozygote | Early adult | 4.91x10-5 |
| | | | | | | | | |
External links
No external links available for Nos2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Nos2em1(IMPC)Bay | Exon Deletion | | mouse |
Nos2tm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell |
Nos2tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Nos2tm2a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |